Malignant lymphatic and hematopoietic neoplasms mortality in Serbia, 1991-2010: A joinpoint regression analysis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Ilic, Milena ^a   Ilic, Irena ^a  

^a University of Kragujevac Medical Faculty   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CHILD; COMPARATIVE STUDY; FEMALE; HEMATOPOIETIC SYSTEM TUMOR; HODGKIN DISEASE; HUMAN; JOINPOINT REGRESSION ANALYSIS; LYMPHATIC LEUKEMIA; LYMPHATIC SYSTEM TUMOR; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; MULTIPLE MYELOMA; MYELOID LEUKEMIA; NEWBORN; NONHODGKIN LYMPHOMA; REGRESSION ANALYSIS; SERBIA; SEX DIFFERENCE; TREND STUDY; AGE; CAUCASIAN; HEMATOLOGIC DISEASE; INFANT; LYMPHOMA; MORTALITY; PRESCHOOL CHILD; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMATOLOGIC NEOPLASMS; HODGKIN DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOMA; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SERBIA; SEX FACTORS; YOUNG ADULT;

EID: 84908199173     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109379     Document Type: Article

References (59)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
3. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84: 1-12.
4. Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, et al. (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110: 695-708.
5. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
6. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon (France): International Agency for Research on Cancer. Available: http://globocan.iarc.fr. Accessed: November 19, 2013.
7. Bertuccio P, Bosetti C, Malvezzi M, Levi F, Chatenoud L, et al. (2013) Trends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012. Int J Cancer 132: 427-36.
8. Bosetti C, Levi F, Ferlay J, Lucchini F, Negri E, et al. (2008) Incidence and mortality from non-Hodgkin lymphoma in Europe: the end of an epidemic? Int J Cancer 123: 1917-23.
9. Coory M, Gill D (2008) Decreasing mortality from non-Hodgkin lymphoma in Australia. Intern Med J 38: 921-4.
10. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, et al. (eds) (2013) SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975/2010/, based on November 2012 SEER data submission, posted to the SEER web site, December 2013.
11. Bosetti C, Levi F, Ferlay J, Lucchini F, Negri E, et al. (2009) The recent decline in mortality from Hodgkin lymphomas in central and eastern Europe. Ann Oncol 20: 767-74.
12. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2002) Trends in mortality from Hodgkin's disease in western and eastern Europe. Br J Cancer 87: 291-3.
13. Montella M, Malvezzi M, Grimaldi M, Nocerino F, Frigeri F, et al. (2013) Mortality trend for tumor correlated immune system in hyperendemic area of HCV infection in southern Italy: joinpoint analysis. Hepat Mon 13: e12725.
14. Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, et al. (2008) Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol 19: 631-40.
15. Statistical Office of the Republic of Serbia. Demographic Yearbook in the Republic of Serbia, 1991-2010 (2011) Belgrade (Serbia): Statistical Office of the Republic of Serbia.
16. The By-law document of emission and form of certificate of death [in Serbian]. Official Gazette SR Serbia 8/2005.
17. Jensen OM, Parkin DM, Lennan R, Muir CS, Skeet RG (1991) Cancer registration. Principles and methods. Lyon: International Agency for Research on Cancer.
18. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19: 335-51.
19. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards B (2009) Estimating average annual per cent change in trend analysis. Stat Med 28: 3670-82.
20. Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ (2004) Comparability of segmented line regression models. Biometrics 60: 1005-14.
21. Novak I, Jaksić O, Kulis T, Batinjan K, Znaor A (2012) Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009. Croat Med J 53: 115-23.
22. Clarke CA, Glaser SL (2002) Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 94: 2015-23.
23. Storm HH, Klint A, Tryggvadó ttir L, Gislum M, Engholm G, et al. (2010) Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 49: 694-712.
24. Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR (2010) Changing cancer incidence in Kampala, Uganda, 1991-2006. Int J Cancer 126: 1187-95.
25. Shiels MS, Engels EA, Linet MS, Clarke CA, Li J, et al. (2013) The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomarkers Prev 22: 1069-78.
26. Dal Maso L, Franceschi S (2006) Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 15: 2078-85.
27. Karami S, Bassig B, Stewart PA, Lee KM, Rothman N, et al. (2013) Occupational trichloroethylene exposure and risk of lymphatic and haematopoietic cancers: a meta-analysis. Occup Environ Med 70: 591-9.
28. Larsson SC, Wolk A (2011) Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer 47: 2422-30.
29. Castillo JJ, Mull N, Reagan JL, Nemr S, Mitri J (2012) Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood 119: 4845-850.
30. Sergentanis TN, Kanavidis P, Michelakos T, Petridou ET (2013) Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease. Eur J Cancer Prev 22: 131-150.
31. Chen GC, Lv DB, Pang Z, Liu QF (2013) Fruits and vegetables consumption and risk of non-Hodgkin's lymphoma: a meta-analysis of observational studies. Int J Cancer 133: 190-200.
32. Tramacere I, Pelucchi C, Bonifazi M, Bagnardi V, Rota M, et al. (2012) Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a metaanalysis. Ann Oncol 23: 2791-8.
33. Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, et al. (1996) Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med 334: 1011-7.
34. Verdecchia A, Santaquilani M, Sant M (2009) Survival for cancer patients in Europe. Ann Ist Super Sanita 45: 315-24.
35. Kunitz SJ (2004) The making and breaking of Yugoslavia and its impact on health. Am J Public Health 94: 1894-904.
36. (1993) The Impact of UN Security Council Sanctions on the Health of the Population of FR Yugoslavia. Belgrade: Federal Ministry for Labour, Health and Social Policy, Federal Institute for Public Health.
37. Hajder J, Marisavljevic D, Stanisavljevic N, Mihaljevic B, Kovcin V, et al. (2012) Biological and clinical features of non-Hodgkin's lymphoma in the elderly. J BUON 17: 753-60.
38. Institute of Public Health of the Republic of Serbia ''Dr Milan Jovanovic Batut'' (2008) Health of the population of Serbia, Analytical Study 1997-2007. Belgrade, Institute of Public Health of the Republic of Serbia.
39. Center for Prevention and Control of Noncommunicable Diseases (2003-2010) Cancer incidence and mortality in Central Serbia, 1999-2010. Institute of Public Health of Serbia ''Dr. Milan Jovanovic Batut'', Belgrade.
40. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD (2005) Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ 83: 171-7.
41. Mihaljević B, Jaković L, Bogdanović A (2010) ABVD as the standard therapeutic protocol in the treatment of Hodgkin's lymphoma - the experience of Serbian lymphoma group. Acta clinica 10: 33-48. (In Serbian)
42. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, et al. (2013) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 2013 Oct 25. doi: 10.1038/leu.2013.313.
43. Scudla V, Bacovsky J, Indrak K, Kodouskova V, Vytrasova M, et al. (2003) Czech Myeloma Group. Results of therapy and changing prognosis of multiple myeloma during the last 40 years in the region of North and Middle Moravia: group of 562 patients. Hematol J 4: 351-7.
44. Gluzman D, Imamura N, Sklyarenko L, Nadgornaya V, Zavelevich M, et al. (2006) Patterns of hematological malignancies in Chernobyl clean-up workers (1996-2005). Exp Oncol 28: 60-3.
45. Vlajinac HD, Pekmezović TD, Adanja BJ, Marinković JM, Kanazir MS, et al. (2003) Case-control study of multiple myeloma with special Reference to diet as risk factor. Neoplasma 50: 79-83.
46. Takkouche B, Regueira-Méndez C, Montes-Martínez A (2009) Risk of cancer among hairdressers and related workers: a meta-analysis. Int J Epidemiol 38: 1512-531.
47. Ministry of Health, Republic of Serbia (2007) National Health Survey, Serbia 2006. Key findings. Belgrade: Ministry of Health, Republic of Serbia.
48. Levi F, Lucchini F, Negri E, Barbui T, La Vecchia C (2000) Trends in mortality from leukemia in subsequent age groups. Leukemia 14: 1980-5.
49. Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, et al. (2008) Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev 17: 3069-75.
50. Balasubramaniam G, Saoba SL, Sarhade MN, Kolekar SA (2013) Lifestyle factors including diet and leukemia development: a case-control study from Mumbai, India. Asian Pac J Cancer Prev 14: 5657-61.
51. International Agency for Research on Cancer. (2004) IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. Vol. 83. Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC. Available: http://globocan.iarc.fr. Accessed November 19, 2013.
52. Jakovljevic K, Malisic E, Cavic M, Radulovic S, Jankovic R (2012) Association between methylenetetrahydrofolate reductase polymorphism C677T and risk of chronic myeloid leukemia in Serbian population. Leuk Lymphoma 53: 1327-30.
53. Markovic-Denic L, Jankovic S, Marinkovic J, Radovanovic Z (1995) Brick mortar exposure and chronic lymphocytic leukemia. Neoplasma 42: 79-81.
54. Bikit I, Varga E, Conkić Lj, Slivka J, Mrda D, et al. (2005) Radioactivity of the Bega sediment-case study of a contaminated canal. Appl Radiat Isot 63: 261-6.
55. Pastor-Barriuso R, López-Abente G (2014) Changes in period and cohort effects on haematological cancer mortality in Spain, 1952-2006. BMC Cancer 14:250. doi: 10.1186/1471-2407-14-250.
56. The European Society for Medical Oncology. ESMO Clinical Practice Guidelines: Haematological Malignancies. Available: http://www.esmo.org/Guidelines-Practice/Clinical-Practice-Guidelines/Haematologic-Malignancies based on June 2014, posted to the web site, June 2014.
57. Kovačević AM, Rančić NK, Tarabar DK, Dragojević-Simić VM (2014) Targeted Therapy and Its Availability in Serbia. Hospital Pharmacology 1: 93-101.
58. Medicines and Medical Devices Agency of Serbia. Medicinal Products. Available: http://www.alims.gov.rs/eng/about-agency/based on June 2014, posted to the web site June 2014.
59. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, et al. (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49: 1374-403.